Quick Answer
GLOBUS MEDICAL INC reported Stockholders Equity of $4.57 billion for fiscal year 2025.
GLOBUS MEDICAL INC Stockholders Equity — Annual History
| Fiscal Year | Stockholders Equity | YoY Change |
|---|---|---|
| 2025 | $4.57B | +9.5% |
| 2024 | $4.18B | +4.5% |
| 2023 | $4.00B | +116.5% |
| 2022 | $1.85B | +4.7% |
| 2022 | $1.76B | +3.8% |
| 2022 | $1.70B | -4.8% |
| 2022 | $1.79B | +2.5% |
| 2021 | $1.74B | +1.3% |
| 2021 | $1.72B | +4.8% |
| 2021 | $1.64B | +4.9% |
| 2021 | $1.56B | +3.8% |
| 2020 | $1.51B | +6.3% |
| 2020 | $1.42B | +6.0% |
| 2020 | $1.34B | -1.9% |
| 2020 | $1.36B | -2.8% |
| 2019 | $1.40B | +4.8% |
| 2019 | $1.34B | +4.0% |
| 2019 | $1.29B | +4.1% |
| 2019 | $1.24B | +4.4% |
| 2018 | $1.19B | +3.9% |
| 2018 | $1.14B | +4.0% |
| 2018 | $1.10B | +6.8% |
| 2018 | $1.03B | +6.1% |
| 2017 | $967.78M | +16.3% |
| 2016 | $832.08M | +16.3% |
| 2015 | $715.32M | +22.2% |
| 2014 | $585.45M | +23.9% |
| 2013 | $472.36M | +22.2% |
| 2012 | $386.50M | +36.8% |
| 2011 | $282.48M | — |
Quarterly Stockholders Equity
| Quarter Ending | Stockholders Equity | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | $4.40B | +8.1% | +2.4% |
| June 30, 2025 | $4.30B | +8.0% | +5.1% |
| March 31, 2025 | $4.09B | +4.2% | -2.1% |
| December 31, 2024 | $4.18B | +4.5% | +2.7% |
| September 30, 2024 | $4.07B | -2.8% | +2.3% |
| June 30, 2024 | $3.98B | +100.3% | +1.4% |
| March 31, 2024 | $3.92B | +104.8% | -1.9% |
| December 31, 2023 | $4.00B | +116.5% | -4.5% |
- GLOBUS MEDICAL INC showed an increase of +9.5% in Stockholders Equity compared to the prior fiscal year.
- Over the 2011–2025 period, GLOBUS MEDICAL INC’s stockholders equity has grown by 1519.0% (from $282.48 million to $4.57 billion).
- The most recent figure is from GLOBUS MEDICAL INC’s fiscal year 2025 report (Form 10-K), filed with the SEC on February 24, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: